FDA approves new treatment for Alzheimer’s disease | WNT

BioGen’s “Aduhelm” is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The FDA granted the drug approval as a new clinical trial begins.

WATCH THE FULL EPISODE OF ‘WORLD NEWS TONIGHT’:
https://bit.ly/3x3Vkgr

WATCH OTHER FULL EPISODES OF WORLD NEWS TONIGHT:
http://abc.go.com/shows/world-news-tonight

WATCH WORLD NEWS TONIGHT ON HULU:
https://bit.ly/3iQLwPp

#WorldNewsTonight #Alzheimers #NewTreatment